Jun
2026
Shanghai New International Expo Center
Visit us
stand E3A50, Finished Dosage
Zone

HANGZHOU ZLFP CO., LTD

About Us

Company Profile Hangzhou ZLFP Co., Ltd. specializes in the production and export of human pharmaceuticals, offering one-stop services including product registration and OEM manufacturing. With outstanding quality, excellent service, and highly competitive pricing, the company has expanded its business to over 100 countries worldwide, boasting a substantial number of registered products. Corporate Vision To create value for global customers through exceptional products and professional services, achieving win-win development with partners. Corporate Mission Driven by innovation, we are committed to providing high-quality pharmaceutical products and solutions for human health. Core Values Customer first, quality-oriented, working hand in hand with global buyers to build a better future. Product Overview Artemether Injection is an antimalarial drug with Artemether as its active ingredient, belonging to the artemisinin derivative class. It works by rapidly killing Plasmodium schizonts in red blood cells, making it particularly suitable for the treatment of severe malaria (including cerebral malaria) and chloroquine-resistant Plasmodium falciparum malaria. Indications Primarily used for the treatment of severe or complicated malaria caused by Plasmodium falciparum, especially in cases resistant to conventional antimalarial drugs such as chloroquine. Also applicable for emergency treatment of other malaria types, particularly when oral antimalarial drugs are unavailable or absorption is impaired.

  • Country/Region:
    China
  • On CPHI since:
    2025
Contact info
  • Room 1005, Unit 1, Building 2, Modern Impression Plaza, Puyan Street, Binjiang District, Hangzhou City, Zhejiang Province, Hangzhou, Zhejiang, China
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand E3A50, Finished Dosage